Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
86.95 -2.68 / -2.99%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
87.00 +0.05 / +0.06%
Volume: 210.6K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues2.3B2.2B2.7B2.8B
Cost of Goods Sold537.1M532.9M635.5M601.0M
Depreciation And Amortization434.3M407.0M635.0M700.4M
Operating ExpensesGross Income1.3B1.3B1.5B1.5B
General Expenses583.6M629.6M766.6M799.2M
Other Operating Expenses0.006.1M176.9M5.2M
Research And Development59.1M55.8M81.1M101.6M
Total Operating Expenses1.6B1.6B2.2B2.1B
Non-Operating ExpensesOperating Income725.0M615.3M518.4M681.0M
Extraordinary Credit28.9M0.000.000.00
Extraordinary Charge-138.7M-91.9M-176.9M-233.2M
Interest Expense On Debt223.7M297.8M412.7M420.2M
Other Expenses198.6M-71.1M5.6M-34.0M
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income590.1M155.4M-64.7M-5.7M
Income Taxes-56.0M-80.9M-13.1M-57.4M
Minority Interest-800.0K-800.0K-1.4M-2.2M
Net Income534.9M73.7M-53.0M49.5M
Shares To Calculate EPSShares To Calculate EPS335.8M336.8M344.4M344.9M
Shares To Calculate EPS Diluted341.9M343.4M344.4M351.0M
Earnings Per ShareEPS$1.59$0.22-$0.15$0.14
EPS Diluted$1.56$0.21-$0.15$0.14